Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 376

1.

Effect of cyclosporine coadministration on the pharmacokinetics of eltrombopag in healthy volunteers.

Aslanis V, Zhang J, Lomeli B, Grosch K, Ouatas T.

Cancer Chemother Pharmacol. 2018 Nov;82(5):847-855. doi: 10.1007/s00280-018-3677-6. Epub 2018 Aug 31.

PMID:
30171280
2.

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.

Tang C, Chen F, Kong D, Ma Q, Dai H, Yin J, Li Z, Chen J, Zhu X, Mao X, Wu D, Tang X.

J Hematol Oncol. 2018 Aug 16;11(1):103. doi: 10.1186/s13045-018-0649-6.

3.

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists.

Guitton Z, Terriou L, Lega JC, Nove-Josserand R, Hie M, Amoura Z, Bussel JB, Hamidou M, Rosenthal E, Lioger B, Chauveau D, Chaminade A, Magy-Bertrand N, Michel M, Audia S, Godeau B, Mahevas M.

Rheumatology (Oxford). 2018 Aug 1;57(8):1432-1438. doi: 10.1093/rheumatology/key119.

PMID:
29757439
4.

Treatment characteristics, efficacy and safety of thrombopoietin analogues in routine management of primary immune thrombocytopenia.

Mingot-Castellano ME, Caparrós IS, Fernández F, Perera-Alvarez MDM, Jimenez-Bárcenas R, Casaus García A, González-Silva M, Yera-Cobo M, Nieto-Hernandez MM, Rodríguez-Fernandez MJ, Díaz-Canales D.

Blood Coagul Fibrinolysis. 2018 Jun;29(4):374-380. doi: 10.1097/MBC.0000000000000726.

PMID:
29738335
5.

Eltrombopag-Induced Acute Liver Failure in a Pediatric Patient: A Pharmacokinetic and Pharmacogenetic Analysis.

Marano M, Serafinelli J, Cairoli S, Martinelli D, Pisani M, Palumbo G, Cefalo MG, Cecchetti C, Di Nardo M, Falvella FS, Goffredo BM.

Ther Drug Monit. 2018 Aug;40(4):386-388. doi: 10.1097/FTD.0000000000000522.

PMID:
29683873
6.

Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia.

Agnelli Giacchello J, Valeri F, Boccadoro M, Borchiellini A.

Eur J Haematol. 2018 Mar;100(3):304-307. doi: 10.1111/ejh.13014. Epub 2018 Jan 15.

PMID:
29243329
7.

Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.

Mittelman M, Platzbecker U, Afanasyev B, Grosicki S, Wong RSM, Anagnostopoulos A, Brenner B, Denzlinger C, Rossi G, Nagler A, Garcia-Delgado R, Portella MSO, Zhu Z, Selleslag D.

Lancet Haematol. 2018 Jan;5(1):e34-e43. doi: 10.1016/S2352-3026(17)30228-4. Epub 2017 Dec 11.

PMID:
29241762
8.

A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag.

Suzuki N, Hiraga J, Hariyama Y, Takagi Y, Ohashi H, Kishigami Y, Oguchi H, Kagami Y.

Int J Hematol. 2018 Jul;108(1):109-111. doi: 10.1007/s12185-017-2383-1. Epub 2017 Nov 29.

PMID:
29188582
9.

Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.

Zhang X, Chuai Y, Nie W, Wang A, Dai G.

Cochrane Database Syst Rev. 2017 Nov 27;11:CD012035. doi: 10.1002/14651858.CD012035.pub2. Review.

PMID:
29178132
10.

A sticky situation: myocardial infarction in a young woman with immune thrombocytopenia on eltrombopag and a history of mediastinal radiation.

Teichman J, Taher A, Hashi A, Bagai A, Sholzberg M.

J Thromb Thrombolysis. 2018 Jan;45(1):192-195. doi: 10.1007/s11239-017-1577-y.

PMID:
29101508
11.

Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.

Gao Y, Gong M, Zhang C, Kong X, Ma Y.

Medicine (Baltimore). 2017 Oct;96(43):e8337. doi: 10.1097/MD.0000000000008337.

12.

Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study.

Wong RSM, Saleh MN, Khelif A, Salama A, Portella MSO, Burgess P, Bussel JB.

Blood. 2017 Dec 7;130(23):2527-2536. doi: 10.1182/blood-2017-04-748707. Epub 2017 Oct 17. Erratum in: Blood. 2018 Feb 8;131(6):709.

PMID:
29042367
13.

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

Cantoni S, Carpenedo M, Mazzucconi MG, De Stefano V, Carrai V, Ruggeri M, Specchia G, Vianelli N, Pane F, Consoli U, Artoni A, Zaja F, D'adda M, Visentin A, Ferrara F, Barcellini W, Caramazza D, Baldacci E, Rossi E, Ricco A, Ciminello A, Rodeghiero F, Nichelatti M, Cairoli R.

Am J Hematol. 2018 Jan;93(1):58-64. doi: 10.1002/ajh.24935. Epub 2017 Nov 9.

PMID:
28983953
14.

Effect of thrombopoietin receptor agonists on leukocyte and haematopoietic stem and progenitor cells in the peripheral blood of patients with immune thrombocytopenic purpura.

Bal G, Fabian D, Maia D, Ringel F, Salama A.

Ann Hematol. 2017 Dec;96(12):2045-2056. doi: 10.1007/s00277-017-3131-6. Epub 2017 Sep 30.

PMID:
28965224
15.

Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia.

Zhao X, Feng X, Wu Z, Winkler T, Desmond R, Olnes M, Dumitriu B, Townsley DM, Dunbar CE, Young NS.

Exp Hematol. 2018 Feb;58:39-43. doi: 10.1016/j.exphem.2017.09.006. Epub 2017 Sep 20.

16.

Comparative treatment-related adverse event cost burden in immune thrombocytopenic purpura.

Donga PZ, Bilir SP, Little G, Babinchak T, Munakata J.

J Med Econ. 2017 Nov;20(11):1200-1206. doi: 10.1080/13696998.2017.1370425. Epub 2017 Sep 8.

PMID:
28882075
17.

Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study.

Winer ES, Safran H, Karaszewska B, Bauer S, Khan D, Doerfel S, Burgess P, Kalambakas S, Mostafa Kamel Y, Forget F.

Int J Hematol. 2017 Dec;106(6):765-776. doi: 10.1007/s12185-017-2319-9. Epub 2017 Sep 1.

PMID:
28864871
18.

Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.

Vlachodimitropoulou E, Chen YL, Garbowski M, Koonyosying P, Psaila B, Sola-Visner M, Cooper N, Hider R, Porter J.

Blood. 2017 Oct 26;130(17):1923-1933. doi: 10.1182/blood-2016-10-740241. Epub 2017 Sep 1.

PMID:
28864815
19.

Clinical outcomes in adult patients with aplastic anemia: A single institution experience.

Boddu P, Garcia-Manero G, Ravandi F, Borthakur G, Jabbour E, DiNardo C, Jain N, Daver N, Pemmaraju N, Anderlini P, Parmar S, Kc D, Akosile M, Pierce SA, Champlin R, Cortes J, Kantarjian H, Kadia T.

Am J Hematol. 2017 Dec;92(12):1295-1302. doi: 10.1002/ajh.24897. Epub 2017 Sep 25.

PMID:
28850699
20.

Thrombopoietin-receptor agonists for children with immune thrombocytopenia: a systematic review.

Zhang J, Liang Y, Ai Y, Xie J, Li Y, Zheng W.

Expert Opin Pharmacother. 2017 Oct;18(15):1543-1551. doi: 10.1080/14656566.2017.1373091. Epub 2017 Sep 4. Review.

PMID:
28845713

Supplemental Content

Loading ...
Support Center